Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

Oral paclitaxel plus encequidar improved tumor response and caused less neuropathy but more serious infections than intravenous paclitaxel.

The new nanoparticles could improve melanoma treatment by working better than current options.

Tofacitinib is effective and safe for treating severe alopecia areata and related conditions.

An 11-year-old girl with a hair-pulling disorder had a hairball in her stomach and was treated with medication, therapy, and a team of doctors.

The gel is a safe and effective treatment for hyperpigmentation.

Tofacitinib effectively treats Alopecia Areata.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

The technique effectively repairs skin after tumor removal, maintaining appearance and function without complications.

Oral tofacitinib has a moderate success rate and is generally safe for treating hair loss in some patients.

Tofacitinib works well for treating alopecia areata, especially when combined with corticosteroids, but is less effective if the disease has lasted over 2 years.

An intact skin barrier is crucial to prevent infection in cases of tether-induced tenosynovitis.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

A new treatment using nanoparticles can effectively prevent and reduce hair loss caused by chemotherapy.

Topical tretinoin 0.01% cream effectively treats eruptive vellus hair cysts.

TAK-279 effectively reduces psoriasis symptoms and is safe.

Early detection and treatment of hair-thread tourniquet syndrome in young girls is important to prevent serious harm.

TEDAR is crucial for skin cell differentiation and barrier formation.

The lotion CG428 did not show effectiveness in treating permanent hair loss in breast cancer survivors.

An 11-year-old girl with Trichotillomania developed a large hairball in her stomach, treated with medication, therapy, and family education.

Researchers created a mouse with the same mutation as humans with trichothiodystrophy, showing similar symptoms and confirming the condition is due to defects in DNA repair and gene activity.

A patient with alopecia had hair regrowth with tofacitinib but developed a skin reaction, choosing to continue the treatment despite the side effect.

Tofacitinib was more effective than methotrexate for treating alopecia areata.

An 86-year-old man had a rare tongue melanoma but refused treatment, showing the need for early cancer detection and treatment.

Tofacitinib can be effective in treating hair loss caused by alopecia areata.

Ritlecitinib improved hair regrowth and emotional well-being in some alopecia areata patients.

Tacalcitol cream effectively and safely treated a rare skin condition called Lichen Spinulosus in two cases.

Patients on dabrafenib and trametinib for melanoma often experience skin side effects.